Franklin Resources Inc Iovance Biotherapeutics, Inc. Transaction History

Franklin Resources Inc

  • $346 Billion
  • Q3 2024

A detailed history of Franklin Resources Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 100,229 shares of IOVA stock, worth $815,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,229
Previous 91,759 9.23%
Holding current value
$815,864
Previous $735,000 28.03%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$7.28 - $11.9 $61,661 - $100,793
8,470 Added 9.23%
100,229 $941,000
Q2 2024

Aug 14, 2024
BUY
$7.78 - $14.19 $401,899 - $733,027
51,658 Added 128.82%
91,759 $735,000
Q1 2024

May 13, 2024
BUY
$7.59 - $17.47 $32,887 - $75,697
4,333 Added 12.11%
40,101 $594,000
Q4 2023

Feb 09, 2024
BUY
$3.3 - $8.89 $35,478 - $95,576
10,751 Added 42.97%
35,768 $290,000
Q3 2023

Nov 13, 2023
BUY
$4.44 - $8.79 $29,632 - $58,664
6,674 Added 36.38%
25,017 $113,000
Q2 2023

Aug 11, 2023
SELL
$5.36 - $9.06 $14.4 Million - $24.3 Million
-2,681,640 Reduced 99.32%
18,343 $129,000
Q1 2023

May 12, 2023
SELL
$5.53 - $8.22 $3.31 Million - $4.93 Million
-599,239 Reduced 18.16%
2,699,983 $16.5 Million
Q4 2022

Feb 10, 2023
SELL
$5.62 - $10.0 $10.6 Million - $18.8 Million
-1,882,924 Reduced 36.33%
3,299,222 $21.1 Million
Q3 2022

Nov 14, 2022
BUY
$9.53 - $13.11 $139,509 - $191,917
14,639 Added 0.28%
5,182,146 $49.6 Million
Q2 2022

Aug 11, 2022
SELL
$6.38 - $18.33 $1.4 Million - $4.02 Million
-219,071 Reduced 4.07%
5,167,507 $57 Million
Q1 2022

May 13, 2022
SELL
$12.38 - $19.1 $5.09 Million - $7.85 Million
-411,138 Reduced 7.09%
5,386,578 $89.7 Million
Q4 2021

Feb 11, 2022
SELL
$16.55 - $27.63 $7.81 Million - $13 Million
-471,707 Reduced 7.52%
5,797,716 $111 Million
Q3 2021

Nov 12, 2021
SELL
$20.35 - $26.63 $19.5 Million - $25.5 Million
-957,650 Reduced 13.25%
6,269,423 $155 Million
Q2 2021

Aug 13, 2021
SELL
$16.33 - $33.07 $29.1 Million - $59 Million
-1,783,897 Reduced 19.8%
7,227,073 $188 Million
Q1 2021

May 13, 2021
BUY
$28.67 - $52.59 $2.35 Million - $4.32 Million
82,066 Added 0.92%
9,010,970 $285 Million
Q4 2020

Feb 10, 2021
BUY
$28.04 - $50.26 $17.1 Million - $30.7 Million
610,359 Added 7.34%
8,928,904 $414 Million
Q3 2020

Nov 12, 2020
BUY
$27.75 - $36.3 $37.7 Million - $49.3 Million
1,358,111 Added 19.51%
8,318,545 $274 Million
Q2 2020

Aug 13, 2020
BUY
$27.21 - $41.0 $47.1 Million - $70.9 Million
1,729,557 Added 33.06%
6,960,434 $203 Million
Q1 2020

May 13, 2020
SELL
$19.54 - $38.85 $4.82 Million - $9.59 Million
-246,879 Reduced 4.51%
5,230,877 $157 Million
Q4 2019

Feb 12, 2020
SELL
$17.95 - $29.41 $19.6 Million - $32 Million
-1,089,720 Reduced 16.59%
5,477,756 $152 Million
Q3 2019

Nov 14, 2019
SELL
$17.99 - $26.0 $8.77 Million - $12.7 Million
-487,506 Reduced 6.91%
6,567,476 $120 Million
Q2 2019

Aug 14, 2019
SELL
$9.78 - $24.52 $12 Million - $30.2 Million
-1,229,917 Reduced 14.85%
7,054,982 $173 Million
Q1 2019

May 14, 2019
BUY
$8.41 - $11.26 $12,068 - $16,158
1,435 Added 0.02%
8,284,899 $78.8 Million
Q4 2018

Feb 12, 2019
BUY
$7.51 - $11.93 $23.3 Million - $37 Million
3,099,311 Added 59.78%
8,283,464 $73.3 Million
Q3 2018

Nov 13, 2018
SELL
$11.25 - $17.7 $1.4 Million - $2.21 Million
-124,782 Reduced 2.35%
5,184,153 $58.3 Million
Q2 2018

Aug 14, 2018
SELL
$12.45 - $16.95 $15,288 - $20,814
-1,228 Reduced 0.02%
5,308,935 $68 Million
Q1 2018

May 10, 2018
BUY
$8.1 - $19.5 $2.68 Million - $6.45 Million
330,697 Added 6.64%
5,310,163 $89.7 Million
Q4 2017

Feb 14, 2018
SELL
$6.65 - $9.25 $1.5 Million - $2.09 Million
-225,825 Reduced 4.34%
4,979,466 $39.8 Million
Q3 2017

Nov 13, 2017
BUY
$4.45 - $8.55 $23.2 Million - $44.5 Million
5,205,291
5,205,291 $40.3 Million

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email